Combining Molecular Scaffolds from FDA Approved Drugs: Application to Drug Discovery

Journal of Medicinal Chemistry

Volumn 60, Issue 5, 2017, Pages 1638-1647

  Taylor, Richard D ^a   MacCoss, Malcolm ^b   Lawson, Alastair D G ^a  

^a UCB Group   (United Kingdom)

^b Bohicket Pharma Consulting LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR SCAFFOLD; MOLECULAR LIBRARY;

ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL DATABASE; DRUG DEVELOPMENT; FOOD AND DRUG ADMINISTRATION; MEDICINAL CHEMISTRY; MOLECULAR LIBRARY; DRUG APPROVAL; LEGISLATION AND JURISPRUDENCE; UNITED STATES;

DRUG APPROVAL; DRUG DISCOVERY; SMALL MOLECULE LIBRARIES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 85015093671     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.6b01367     Document Type: Article

References (28)

1. Paul, S. M.; Mytelka, D. S.; Dunwiddie, C. T.; Persinger, C. C.; Munos, B. H.; Lindborg, S. R.; Schacht, A. L. How To Improve R&D Productivity: The Pharmaceutical Industry’s Grand Challenge Nat. Rev. Drug Discovery 2010, 9 ( 3 ) 203-214 10.1038/nrd3078
2. Kola, I.; Landis, J. Can the Pharmaceutical Industry Reduce Attrition Rates? Nat. Rev. Drug Discovery 2004, 3 ( 8 ) 711-715 10.1038/nrd1470
3. Ruddigkeit, L.; van Deursen, R.; Blum, L. C.; Reymond, J.-L. Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17 J. Chem. Inf. Model. 2012, 52 ( 11 ) 2864-2875 10.1021/ci300415d
4. Bohacek, R. S.; McMartin, C.; Guida, W. C. The Art and Practice of Structure-Based Drug Design: A Molecular Modeling Perspective Med. Res. Rev. 1996, 16 ( 1 ) 3-50 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6
5. Ertl, P. Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups J. Chem. Inf. Comput. Sci. 2003, 43 ( 2 ) 374-380 10.1021/ci0255782
6. Manojlović, L. M. Photometry-Based Estimation of the Total Number of Stars in the Universe Appl. Opt. 2015, 54 ( 21 ) 6589-6591 10.1364/AO.54.006589
7. Welsch, M. E.; Snyder, S. A.; Stockwell, B. R. Privileged Scaffolds for Library Design and Drug Discovery Curr. Opin. Chem. Biol. 2010, 14 ( 3 ) 347-361 10.1016/j.cbpa.2010.02.018
8. Kombarov, R.; Altieri, A.; Genis, D.; Kirpichenok, M.; Kochubey, V.; Rakitina, N.; Titarenko, Z. BioCores: Identification of a Drug/natural Product-Based Privileged Structural Motif for Small-Molecule Lead Discovery Mol. Diversity 2010, 14 ( 1 ) 193-200 10.1007/s11030-009-9157-5
9. Kim, J.; Kim, H.; Park, S. B. Privileged Structures: Efficient Chemical “navigators” toward Unexplored Biologically Relevant Chemical Spaces J. Am. Chem. Soc. 2014, 136 ( 42 ) 14629-14638 10.1021/ja508343a
10. Hartenfeller, M.; Eberle, M.; Meier, P.; Nieto-Oberhuber, C.; Altmann, K.-H.; Schneider, G.; Jacoby, E.; Renner, S. Probing the Bioactivity-Relevant Chemical Space of Robust Reactions and Common Molecular Building Blocks J. Chem. Inf. Model. 2012, 52 ( 5 ) 1167-1178 10.1021/ci200618n
11. Lewell, X. Q.; Judd, D. B.; Watson, S. P.; Hann, M. M. RECAP--Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry J. Chem. Inf. Comput. Sci. 1998, 38 ( 3 ) 511-522 10.1021/ci970429i
12. Ertl, P. Database of Bioactive Ring Systems with Calculated Properties and Its Use in Bioisosteric Design and Scaffold Hopping Bioorg. Med. Chem. 2012, 20 ( 18 ) 5436-5442 10.1016/j.bmc.2012.02.058
13. Zhao, H.; Caflisch, A. Current Kinase Inhibitors Cover a Tiny Fraction of Fragment Space Bioorg. Med. Chem. Lett. 2015, 25 ( 11 ) 2372-2376 10.1016/j.bmcl.2015.04.005
14. Reker, D.; Schneider, G. Active-Learning Strategies in Computer-Assisted Drug Discovery Drug Discovery Today 2015, 20 ( 4 ) 458-465 10.1016/j.drudis.2014.12.004
15. Taylor, R. D.; MacCoss, M.; Lawson, A. D. G. Rings in Drugs J. Med. Chem. 2014, 57 ( 14 ) 5845-5859 10.1021/jm4017625
16. Bemis, G. W.; Murcko, M. A. The Properties of Known Drugs. 1. Molecular Frameworks J. Med. Chem. 1996, 39 ( 15 ) 2887-2893 10.1021/jm9602928
17. Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A “Rule of Three” for Fragment-Based Lead Discovery? Drug Discovery Today 2003, 8 ( 19 ) 876-877 10.1016/S1359-6446(03)02831-9
18. Kirkpatrick, P.; Ellis, C. Chemical Space Nature 2004, 432 ( 7019 ) 823-823 10.1038/432823a
19. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: A Large-Scale Bioactivity Database for Drug Discovery Nucleic Acids Res. 2012, 40 ( Database issue ) D1100-D1107 10.1093/nar/gkr777
20. eMolecules Inc. http://www.emolecules.com (accessed October 10, 2015).
21. Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC: A Free Tool to Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52 ( 7 ) 1757-1768 10.1021/ci3001277
22. Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. DrugBank 3.0: A Comprehensive Resource for “Omics” Research on Drugs Nucleic Acids Res. 2011, 39 ( Database issue ) D1035-D1041 10.1093/nar/gkq1126
23. Pence, H. E.; Williams, A. ChemSpider: An Online Chemical Information Resource J. Chem. Educ. 2010, 87 ( 11 ) 1123-1124 10.1021/ed100697w
24. Walters, W. P.; Namchuk, M. Designing Screens: How to Make Your Hits a Hit Nat. Rev. Drug Discovery 2003, 2 ( 4 ) 259-266 10.1038/nrd1063
25. Murray, C. W.; Verdonk, M. L.; Rees, D. C. Experiences in Fragment-Based Drug Discovery Trends Pharmacol. Sci. 2012, 33 ( 5 ) 224-232 10.1016/j.tips.2012.02.006
26. Hann, M. M.; Leach, A. R.; Harper, G. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery J. Chem. Inf. Comput. Sci. 2001, 41 ( 3 ) 856-864 10.1021/ci000403i
27. Jhoti, H.; Williams, G.; Rees, D. C.; Murray, C. W. The “Rule of Three” for Fragment-Based Drug Discovery: Where Are We Now? Nat. Rev. Drug Discovery 2013, 12 ( 8 ) 644-645 10.1038/nrd3926-c1
28. Mok, N. Y.; Brenk, R.; Brown, N. Increasing the Coverage of Medicinal Chemistry-Relevant Space in Commercial Fragments Screening J. Chem. Inf. Model. 2014, 54 ( 1 ) 79-85 10.1021/ci400632y